STOCK TITAN
  1. Home
  2. News
  3. OWLT

Owlet Inc - OWLT STOCK NEWS

Welcome to our dedicated news page for Owlet (Ticker: OWLT), a resource for investors and traders seeking the latest updates and insights on Owlet.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Owlet's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Owlet's position in the market.

News
Owlet Announces Fourth Quarter and Fiscal Year 2023 Results
Rhea-AI Summary
Owlet, Inc. reported strong financial results for Q4 2023 and FY 2023, with revenue of $21.0 million and $54.0 million, respectively. The company's net loss decreased significantly by 65% in Q4 and 59% for FY 2023. Owlet's adjusted EBITDA loss also improved by 95% in Q4 and 76% for FY 2023, showcasing operational efficiency and cost reduction efforts. The company's gross margin increased to 47.1% in Q4 and 41.8% for FY 2023, indicating positive financial performance and growth. Owlet's CEO highlighted the successful commercialization of new medical devices, expansion into healthcare channels, and partnerships for reimbursement, setting a strong foundation for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.97%
Tags
earnings
-
News
Owlet Announces $9 Million Private Placement Financing
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces a private placement of Series B preferred stock and warrants to raise $9 million after recent FDA clearances and strong Q4 results. The transaction offers a 25% premium to the market closing price. The company plans to issue 1.2 million common stock shares and warrants to investors, supporting its momentum in infant monitoring devices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.81%
Tags
none
-
News
Owlet Announces Strong Preliminary Fourth Quarter 2023 Results and to Report Fourth Quarter 2023 Financial Results on March 7, 2024
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) reports strong financial performance in Q4 2023 with Gross Sales of $32.9 million (up 114% YoY), Net Revenue of $21.0 million (up 75% YoY), Gross Margin at 47% (up over 1,900 bps YoY), Net Loss of $6.9 million (down 65% YoY), and adjusted EBITDA loss of $0.7 million (down 95% YoY). The company attributes the positive results to FDA clearances, cost reduction, and operational improvements. Despite non-recurring items impacting gross margin and EBITDA loss, Owlet anticipates continued growth in 2024 through new product commercialization and expanded distribution.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences earnings
News
Owlet to Participate in Cowen’s 44th Annual Health Care Conference
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will participate in the 44th Annual Cowen Health Care Conference. Kurt Workman and Kate Scolnick will engage in a fireside chat on March 5, 2024, at 2:50 p.m. Eastern Time. Investors can access the live webcast on Owlet's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.57%
Tags
conferences
-
News
Owlet Transforms Infant Care with the Launch of Two FDA-Cleared Devices – Dream Sock® and BabySat™
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) announces the launch of Dream Sock and BabySat, two FDA-cleared medical devices for at-home infant monitoring. The devices provide real-time health insights with medical-grade accuracy and aim to help parents monitor their baby's well-being. Dream Sock is a pulse oximetry solution for infants without the need for a prescription, while BabySat is intended for infants with acute or chronic medical conditions. Both devices offer caregivers the ability to track vital signs and receive real-time notifications for low pulse rate and low oxygen levels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
none
-
News
Owlet to Participate in BTIG’s Digital Health Forum
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) to participate in BTIG Digital Health Forum on November 20, 2023. Kurt Workman and Kate Scolnick to engage in fireside chat at 11 a.m. Eastern Time. 1x1 meetings with management available upon request through BTIG.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags
conferences
News
Owlet Announces Third Quarter 2023 Financial Results
Rhea-AI Summary
Owlet, Inc. (NYSE:OWLT) Reports Q3 2023 Financial Results and FDA Authorization for Dream Sock®. Achieved revenues of $9.2 million, de novo FDA-authorization for Dream Sock, and a shift in Amazon revenue arrangement. Operating expenses reduced to $11.2 million compared to $26.4 million in 2022. Gross margin increased to 36.3% from 26.6% in the same period in 2022. Financial outlook to be discussed in the conference call on November 13, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.61%
Tags
earnings
-
News
Owlet Achieves De Novo FDA-Clearance For Dream Sock® – The First and Only Over-the-Counter, Medical Grade Pulse Oximeter Cleared for Infants
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) announces FDA De Novo clearance for Dream Sock, the first over-the-counter medical pulse oximetry solution for infants. The cleared features include monitoring and displaying Baby’s Live Health Readings, pulse rate, and oxygen saturation level, and providing Health Notifications. This sets new standards in at-home infant care, providing enhanced peace of mind for parents.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
none
-
News
Owlet to Report Third Quarter 2023 Financial Results on November 13, 2023
Rhea-AI Summary
Owlet, Inc. (NYSE: OWLT) will release its Q3 2023 results on November 13, 2023. The earnings release will be available on Business Wire and Owlet's Investor Relations website. A conference call will be hosted by CEO Kurt Workman and CFO Kate Scolnick at 4:30 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences earnings
News
Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS
Rhea-AI Summary
Owlet partners with Dr. Harrington and Knox Blocks Foundation to raise funds for SIDS research, aiming to identify biomarkers and develop preventative screenings. SIDS claims over 3,000 babies' lives annually in the US. Owlet donates 5% of global sales in October to the project. Owlet also supports parents through various initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
none
Stock OWLT logo
Owlet Inc

NYSE:OWLT

OWLT Rankings

#4880 Ranked by Market Cap
#5132 Ranked by Stock Gains
N/A Ranked by Dividends

OWLT Stock Data

32.44M
5.70M
11.27%
44.52%
3.34%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Lehi